Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: Protocol for a network meta-analysis of randomized and observational studies
Authors:
- Brian HuttonBHBrian Hutton
- Lawrence JosephLJLawrence Joseph
- Fatemeh YazdiFYFatemeh Yazdi
- Jennifer TetzlaffJTJennifer Tetzlaff
- Mona HersiMHMona Hersi
- Madzouka KokoloMKMadzouka Kokolo
- Nicolas FergussonNFNicolas Fergusson
- Alexandria BennettABAlexandria Bennett
- Chieny BuenaventuraCBChieny Buenaventura
- Dean FergussonDFDean Fergusson
- Andrea TriccoATAndrea Tricco
- Sharon StraussSSSharon Strauss
Open Access
- 22 February 2014
- journal article
- research article
- Published by Springer Nature in Systematic Reviews
- Vol. 3 (1) , 16
Abstract
Patients undergoing renal transplant procedures require multi-agent immunosuppressive regimens both short term (induction phase) and long term (maintenance phase) to minimize the risk of organ rejection. There are several drug classes and agents for immunosuppression. Use of these agents may increase the risk of different harms including not only infections, but also malignancies including post-transplant lymphoproliferative disorder. There is a need to identify which regimens minimize the risk of such outcomes. The objective of this systematic review and network meta-analysis of randomized and observational studies is to explore whether certain modern regimens of immunosuppression used to prevent organ rejection in renal transplant patients are associated with an increased risk of post-transplant lymphoproliferative disorder and other malignancies. ‘Modern’ regimens were defined to be those evaluated in controlled studies beginning in 1990 or later. An electronic literature search of Medline, Embase and the Cochrane Central Register of Controlled Trials has been designed by an experienced information specialist and peer reviewed by a second information specialist. Study selection and data collection will be performed by two reviewers. The outcomes of interest will include post-transplant lymphoproliferative disorder and other incident forms of malignancy occurring in adult renal transplant patients. Network meta-analyses of data from randomized and observational studies will be performed where judged appropriate based on a review of the clinical and methodological features of included studies. A sequential approach to meta-analysis will be used to combine data from different designs. Our systematic review will include both single-agent and multi-agent modern pharmacotherapy regimens in patients undergoing renal transplantation. It will synthesize malignancy outcomes. Our work will also add to the development of methods for network meta-analysis across study designs to assess treatment safety. PROSPERO Registration Number: CRD42013006951Keywords
This publication has 43 references indexed in Scilit:
- Evidence Synthesis for Decision Making 3Medical Decision Making, 2013
- Evidence Synthesis for Decision Making 4Medical Decision Making, 2013
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- An evidence-based practice guideline for the peer review of electronic search strategiesJournal of Clinical Epidemiology, 2009
- Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analysesCanadian Medical Association Journal, 2009
- Bias Modelling in Evidence SynthesisJournal of the Royal Statistical Society Series A: Statistics in Society, 2008
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous DesignsJournal of the American Statistical Association, 1999
- A Bayesian Method for Synthesizing Evidence: The Confidence Profile MethodInternational Journal of Technology Assessment in Health Care, 1990